These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 11736917)
41. Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: an analysis of based on results from the L.I.ON. study. Lamisil versus Itraconazole in Onychomycosis. Jansen R; Redekop WK; Rutten FF Pharmacoeconomics; 2001; 19(4):401-10. PubMed ID: 11383756 [TBL] [Abstract][Full Text] [Related]
42. [The modern approach to the treatment for onychomycosis of hands and feet in the outpatient setting]. Gerasimchuk EV; Gerasimov VV; Molchanov BA Voen Med Zh; 2005 Nov; 326(11):44-5. PubMed ID: 16404907 [No Abstract] [Full Text] [Related]
43. Long-term evaluation of terbinafine 250 and 500 mg daily in a 16-week oral treatment for toenail onychomycosis. De Cuyper C Br J Dermatol; 1996 Jul; 135(1):156-7. PubMed ID: 8776393 [No Abstract] [Full Text] [Related]
44. Cholestatic jaundice due to terbinafine. Dwyer CM; White MI; Sinclair TS Br J Dermatol; 1997 Jun; 136(6):976-7. PubMed ID: 9217846 [No Abstract] [Full Text] [Related]
51. Treatment of toenail onychomycosis. Prescribing terbinafine to every patient with the condition would be expensive. Rose P; Wilson T BMJ; 1999 Oct; 319(7218):1197. PubMed ID: 10610152 [No Abstract] [Full Text] [Related]
52. Severe erythema anulare centrifugum-like psoriatic drug eruption induced by terbinafine. Wach F; Stolz W; Hein R; Landthaler M Arch Dermatol; 1995 Aug; 131(8):960-1. PubMed ID: 7632075 [No Abstract] [Full Text] [Related]
53. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients. Ginter-Hanselmayer G; Weger W; Smolle J J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):470-5. PubMed ID: 18194238 [TBL] [Abstract][Full Text] [Related]